These results suggested that HSF1 is a major contributor to drug resistance against USP7i, supporting that HSF1 is a promising molecular target for overcoming cancer resistance to chemotherapy and providing a plausible strategy for improving chemotherapy efficacy. This evidence concerns the gene HSF1 and cancer.